228 related articles for article (PubMed ID: 32534505)
1. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
[TBL] [Abstract][Full Text] [Related]
2. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury.
Wu Y
Virol Sin; 2020 Jun; 35(3):256-258. PubMed ID: 32034638
[No Abstract] [Full Text] [Related]
3. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.
Drucker DJ
Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32294179
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
Cao Z; Wu Y; Faucon E; Sabatier JM
Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
[No Abstract] [Full Text] [Related]
6. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
Pang X; Cui Y; Zhu Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
[No Abstract] [Full Text] [Related]
7. Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.
Skayem C; Ayoub N
Am J Med Sci; 2020 Sep; 360(3):300. PubMed ID: 32631576
[No Abstract] [Full Text] [Related]
8. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
9. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Carradori S
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
[No Abstract] [Full Text] [Related]
10. Sitagliptin: a potential drug for the treatment of COVID-19?
Bardaweel SK; Hajjo R; Sabbah DA
Acta Pharm; 2021 Jun; 71(2):175-184. PubMed ID: 33151168
[TBL] [Abstract][Full Text] [Related]
11. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
Tsioufis C; Dimitriadis K; Tousoulis D
Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
[No Abstract] [Full Text] [Related]
12. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
Sengupta P; Dutta S
Eur J Contracept Reprod Health Care; 2020 Oct; 25(5):405-406. PubMed ID: 32643968
[No Abstract] [Full Text] [Related]
13. Purposing Saikosaponins for the treatment of COVID-19.
Bahbah EI; Negida A; Nabet MS
Med Hypotheses; 2020 Jul; 140():109782. PubMed ID: 32353743
[No Abstract] [Full Text] [Related]
14. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.
Park J; Jeong D; Chung YW; Kim DH; Cheon JH; Ryu JH
Yonsei Med J; 2020 Oct; 61(10):891-894. PubMed ID: 32975064
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
Ghahestani SM; Mahmoudi J; Hajebrahimi S; Sioofy-Khojine AB; Salehi-Pourmehr H; Sadeghi-Ghyassi F; Mostafaei H
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):13-17. PubMed ID: 32534506
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
Solerte SB; Di Sabatino A; Galli M; Fiorina P
Acta Diabetol; 2020 Jul; 57(7):779-783. PubMed ID: 32506195
[TBL] [Abstract][Full Text] [Related]
17. Potential role of statins in COVID-19.
Lee KCH; Sewa DW; Phua GC
Int J Infect Dis; 2020 Jul; 96():615-617. PubMed ID: 32502659
[TBL] [Abstract][Full Text] [Related]
18. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
Theoharides TC
Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
[No Abstract] [Full Text] [Related]
19. Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19.
Chen CF; Chien CH; Yang YP; Chou SJ; Wang ML; Huo TI; Lin CC
J Chin Med Assoc; 2020 Aug; 83(8):710-711. PubMed ID: 32349031
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of targeting ACE2 in COVID-19.
Elmorsi R
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9744-9747. PubMed ID: 33015820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]